compound semaglutide being discontinued FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many Compounded Semaglutide Injection: GLP-1 weight

Sleep disruption, common during perimenopause and menopause, often contributes to weight gain through increased cortisol and ghrelin levels

For example, if a beneficiary initiated GLP-1 therapy in September 2024 with a body mass index (BMI) of 37 and has a BMI of 34 at the time of a July 2026 prior authorization request, the prescribing provider should attest that the beneficiary met the BMI 35 criterion at the time therapy was initiated

I dont believe that theres a magic pill for getting in shapebeing healthier takes a commitment to total wellness

Managing Digestive Side Effects on GLP-1 Treatment Most gastrointestinal side effects associated with GLP-1 therapy are mild to moderate and tend to improve over time as the body adjusts to treatment

& Santana, M

Versus traditional amylin analogues (pramlintide) Cagrilintide's long-acting formulation allows weekly dosing versus three-times-daily for pramlintide, dramatically improving convenience